326 related articles for article (PubMed ID: 17960246)
1. An elaborate pathway required for Ras-mediated epigenetic silencing.
Gazin C; Wajapeyee N; Gobeil S; Virbasius CM; Green MR
Nature; 2007 Oct; 449(7165):1073-7. PubMed ID: 17960246
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.
Wajapeyee N; Malonia SK; Palakurthy RK; Green MR
Genes Dev; 2013 Oct; 27(20):2221-6. PubMed ID: 24105743
[TBL] [Abstract][Full Text] [Related]
3. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
Mei FC; Young TW; Liu J; Cheng X
FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
[TBL] [Abstract][Full Text] [Related]
4. Silent assassin: oncogenic ras directs epigenetic inactivation of target genes.
Cheng X
Sci Signal; 2008 Apr; 1(13):pe14. PubMed ID: 18385037
[TBL] [Abstract][Full Text] [Related]
5. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
Sugimoto Y; Ikawa Y; Nakauchi H
Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
[TBL] [Abstract][Full Text] [Related]
6. Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells.
Thaler R; Spitzer S; Karlic H; Berger C; Klaushofer K; Varga F
Biochem Pharmacol; 2013 Jan; 85(2):173-85. PubMed ID: 23103563
[TBL] [Abstract][Full Text] [Related]
7. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.
Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM
J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
Yamada H; Omata-Yamada T; Lengyel P
J Biol Chem; 1991 Feb; 266(6):4002-9. PubMed ID: 1995648
[TBL] [Abstract][Full Text] [Related]
10. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model.
Wang Y; Li G; Mao F; Li X; Liu Q; Chen L; Lv L; Wang X; Wu J; Dai W; Wang G; Zhao E; Tang KF; Sun ZS
J Biol Chem; 2014 May; 289(20):14225-38. PubMed ID: 24648519
[TBL] [Abstract][Full Text] [Related]
11. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
[TBL] [Abstract][Full Text] [Related]
12. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
13. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
15. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
[TBL] [Abstract][Full Text] [Related]
16. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
17. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells.
Chatterjee B; Ghosh K; Swain A; Nalla KK; Ravula H; Pan A; Kanade SR
Phytomedicine; 2022 Jan; 95():153885. PubMed ID: 34920321
[TBL] [Abstract][Full Text] [Related]
18. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
[TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
